|
KIFC1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.803600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.716600E-01 |
| Normal-vs-Stage2 |
1.996800E-01 |
| Normal-vs-Stage3 |
9.641400E-01 |
| Normal-vs-Stage4 |
7.061000E-01 |
| Stage1-vs-Stage2 |
1.496140E-03 |
| Stage1-vs-Stage3 |
6.496800E-01 |
| Stage1-vs-Stage4 |
6.650800E-01 |
| Stage2-vs-Stage3 |
2.292300E-02 |
| Stage2-vs-Stage4 |
9.696200E-03 |
| Stage3-vs-Stage4 |
5.022000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.943800E-01 |
| Normal-vs-AfricanAmerican |
5.799400E-01 |
| Normal-vs-Asian |
7.265600E-01 |
| Caucasian-vs-AfricanAmerican |
2.925600E-01 |
| Caucasian-vs-Asian |
8.256800E-01 |
| AfricanAmerican-vs-Asian |
2.051800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.288000E-01 |
| Normal-vs-Female |
9.457600E-01 |
| Male-vs-Female |
6.905400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.210600E-01 |
| Normal-vs-Age(41-60Yrs) |
4.268800E-01 |
| Normal-vs-Age(61-80Yrs) |
8.508800E-01 |
| Normal-vs-Age(81-100Yrs) |
9.803800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.012800E-04 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.770950E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.461000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.364200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.337590E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.804010E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.098000E-01 |
| Classical-VS-Follicular |
4.61539999996319E-07 |
| Classical-VS-Other |
3.143200E-01 |
| Classical-VS-Normal |
6.790400E-01 |
| Tall-VS-Follicular |
9.153900E-04 |
| Tall-VS-Other |
1.851180E-01 |
| Tall-VS-Normal |
5.999600E-01 |
| Follicular-VS-Other |
6.094400E-01 |
| Follicular-VS-Normal |
1.203240E-01 |
| Other-VS-Normal |
4.165000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.615600E-01 |
| Normal-vs-N1 |
8.562200E-01 |
| N0-vs-N1 |
9.793000E-01 |
|
|
